
Sign up to save your podcasts
Or


Noubar Afeyan has started 76 companies over his career. One of those companies is Moderna, the COVID vaccine maker that recently surpassed Merck in market value. Afeyan discusses Moderna’s success and where his firm m, Flagship Pioneering, is looking for its next opportunity.
See omnystudio.com/listener for privacy information.
By Bloomberg4.6
145145 ratings
Noubar Afeyan has started 76 companies over his career. One of those companies is Moderna, the COVID vaccine maker that recently surpassed Merck in market value. Afeyan discusses Moderna’s success and where his firm m, Flagship Pioneering, is looking for its next opportunity.
See omnystudio.com/listener for privacy information.

978 Listeners

2,190 Listeners

2,001 Listeners

2,697 Listeners

1,101 Listeners

2,342 Listeners

943 Listeners

796 Listeners

206 Listeners

147 Listeners

422 Listeners

356 Listeners

298 Listeners

195 Listeners

460 Listeners